{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:51:53Z","timestamp":1790041913073,"version":"4.0.1"},"reference-count":131,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.tips.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T08:29:36Z","timestamp":1564993776000},"page":"669-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Targeting TRP Channels \u2013 Valuable Alternatives to Combat Pain, Lower Urinary Tract Disorders, and Type 2 Diabetes?"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5526-5821","authenticated-orcid":false,"given":"Thomas","family":"Voets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2502-0409","authenticated-orcid":false,"given":"Joris","family":"Vriens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2564-5150","authenticated-orcid":false,"given":"Rudi","family":"Vennekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2019.07.004_bb0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/pr.57.4.6","article-title":"International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels","volume":"57","author":"Clapham","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tips.2019.07.004_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ceca.2017.04.007","article-title":"TRP channel pores and local calcium signals","volume":"66","author":"Mulier","year":"2017","journal-title":"Cell Calcium"},{"key":"10.1016\/j.tips.2019.07.004_bb0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature02196","article-title":"TRP channels as cellular sensors","volume":"426","author":"Clapham","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.07.004_bb0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a035048","article-title":"Transient receptor potential channels and calcium signaling","author":"Vangeel","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.tips.2019.07.004_bb0025","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.bbamcr.2015.04.016","article-title":"Functional and physiopathological implications of TRP channels","volume":"1853","author":"Smani","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2019.07.004_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1152\/physrev.00021.2006","article-title":"Transient receptor potential cation channels in disease","volume":"7","author":"Nilius","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tips.2019.07.004_bb0035","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1124\/pr.113.008268","article-title":"Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine","volume":"66","author":"Nilius","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tips.2019.07.004_bb0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-pharmtox-010617-052832","article-title":"TRP channels as potential drug targets","volume":"58","author":"Moran","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tips.2019.07.004_bb0045","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1185\/03007995.2010.545813","article-title":"Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact","volume":"27","author":"Reid","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.tips.2019.07.004_bb0050","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/535S1a","article-title":"Pain","volume":"535","author":"Grayson","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.07.004_bb0055","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","article-title":"The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013","volume":"54","author":"Florence","year":"2016","journal-title":"Med. Care"},{"key":"10.1016\/j.tips.2019.07.004_bb0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2019.07.004_bb0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMp1704633","article-title":"Gabapentin and pregabalin for pain \u2013 is increased prescribing a cause for concern?","volume":"377","author":"Goodman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2019.07.004_bb0070","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1172\/JCI42843","article-title":"Nociceptors: the sensors of the pain pathway","volume":"120","author":"Dubin","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2019.07.004_bb0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-cellbio-101011-155833","article-title":"TRP channels and pain","volume":"29","author":"Julius","year":"2013","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.tips.2019.07.004_bb0080","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrn3784","article-title":"Peripheral thermosensation in mammals","volume":"15","author":"Vriens","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2019.07.004_bb0085","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: a heat-activated ion channel in the pain pathway","volume":"389","author":"Caterina","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.07.004_bb0090","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature02282","article-title":"Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1","volume":"427","author":"Jordt","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.07.004_bb0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature719","article-title":"Identification of a cold receptor reveals a general role for TRP channels in thermosensation","volume":"416","author":"McKemy","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.07.004_bb0100","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(02)00652-9","article-title":"A TRP channel that senses cold stimuli and menthol","volume":"108","author":"Peier","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.tips.2019.07.004_bb0105","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.neuron.2011.02.051","article-title":"TRPM3 is a nociceptor channel involved in the detection of noxious heat","volume":"70","author":"Vriens","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2019.07.004_bb0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3959(97)00108-5","article-title":"Peripheral CGRP release as a marker for neurogenic inflammation: a model system for the study of neuropeptide secretion in rat paw skin","volume":"73","author":"Kilo","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.tips.2019.07.004_bb0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pain.2010.08.021","article-title":"TRPA1 receptors mediate environmental irritant-induced meningeal vasodilatation","volume":"152","author":"Kunkler","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.tips.2019.07.004_bb0120","doi-asserted-by":"crossref","first-page":"E1363","DOI":"10.1073\/pnas.1419845112","article-title":"Activation of TRPM3 by a potent synthetic ligand reveals a role in peptide release","volume":"112","author":"Held","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2019.07.004_bb0125","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tips.2019.07.004_bb0130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies \u2013 successful translation from bench to clinic","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tips.2019.07.004_bb0135","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1126\/science.1083646","article-title":"A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity","volume":"300","author":"Prescott","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.tips.2019.07.004_bb0140","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/toxins9100326","article-title":"Animal toxins providing insights into TRPV1 activation mechanism","volume":"9","author":"Geron","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2019.07.004_bb0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature05285","article-title":"Spider toxins activate the capsaicin receptor to produce inflammatory pain","volume":"444","author":"Siemens","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.07.004_bb0150","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","article-title":"Impaired nociception and pain sensation in mice lacking the capsaicin receptor","volume":"288","author":"Caterina","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.tips.2019.07.004_bb0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/35012076","article-title":"Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia","volume":"405","author":"Davis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.07.004_bb0160","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1523\/JNEUROSCI.4833-06.2007","article-title":"The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation","volume":"27","author":"Gavva","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.07.004_bb0165","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pain.2008.01.024","article-title":"Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans","volume":"136","author":"Gavva","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.tips.2019.07.004_bb0170","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1517\/13543784.2012.704021","article-title":"Targeting TRPV1 for pain relief: limits, losers and laurels","volume":"21","author":"Szallasi","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.tips.2019.07.004_bb0175","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13038","article-title":"TRPV1 antagonists that cause hypothermia, instead of hyperthermia, in rodents: compounds\u2019 pharmacological profiles, in vivo targets, thermoeffectors recruited and implications for drug development","volume":"223","author":"Garami","year":"2018","journal-title":"Acta Physiol. (Oxford)"},{"key":"10.1016\/j.tips.2019.07.004_bb0180","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1523\/JNEUROSCI.5150-09.2010","article-title":"Contributions of different modes of TRPV1 activation to TRPV1 antagonist-induced hyperthermia","volume":"30","author":"Garami","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.07.004_bb0185","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1164\/rccm.201704-0769OC","article-title":"XEN-D0501, a novel transient receptor potential vanilloid 1 antagonist, does not reduce cough in patients with refractory cough","volume":"196","author":"Belvisi","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.tips.2019.07.004_bb0190","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.pain.2013.02.004","article-title":"TRPV1 antagonistic analgesic effect: a randomized study of AZD1386 in pain after third molar extraction","volume":"154","author":"Quiding","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.tips.2019.07.004_bb0195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1515\/sjpain-2017-0184","article-title":"A multiple-dose double-blind randomized study to evaluate the safety, pharmacokinetics, pharmacodynamics and analgesic efficacy of the TRPV1 antagonist JNJ-39439335 (mavatrep)","volume":"18","author":"Manitpisitkul","year":"2018","journal-title":"Scand. J. Pain"},{"key":"10.1016\/j.tips.2019.07.004_bb0200","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/00365521.2012.758769","article-title":"Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease and a partial response to PPI treatment is not associated with analgesia to esophageal experimental pain","volume":"48","author":"Krarup","year":"2013","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.tips.2019.07.004_bb0205","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5414\/CP202013","article-title":"TRPV1 inhibition does not prevent cold dry air-elicited symptoms in non-allergic rhinitis","volume":"52","author":"Murdoch","year":"2014","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2019.07.004_bb0210","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","volume":"1","author":"Derry","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tips.2019.07.004_bb0215","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S1474-4422(08)70228-X","article-title":"NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study","volume":"7","author":"Backonja","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2019.07.004_bb0220","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nature06191","article-title":"Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers","volume":"449","author":"Binshtok","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.07.004_bb0225","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.2011.01391.x","article-title":"Targeting of sodium channel blockers into nociceptors to produce long-duration analgesia: a systematic study and review","volume":"164","author":"Roberson","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2019.07.004_bb0230","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2015.06.007","article-title":"Silencing nociceptor neurons reduces allergic airway inflammation","volume":"87","author":"Talbot","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2019.07.004_bb0235","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(04)00150-3","article-title":"Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin","volume":"41","author":"Bandell","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2019.07.004_bb0240","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1523\/JNEUROSCI.5369-07.2008","article-title":"Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress","volume":"28","author":"Andersson","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.07.004_bb0245","doi-asserted-by":"crossref","first-page":"28291","DOI":"10.1074\/jbc.M111.328674","article-title":"Methylglyoxal activates nociceptors through transient receptor potential channel A1 (TRPA1): a possible mechanism of metabolic neuropathies","volume":"287","author":"Eberhardt","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2019.07.004_bb0250","doi-asserted-by":"crossref","first-page":"13519","DOI":"10.1073\/pnas.0705923104","article-title":"4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1","volume":"104","author":"Trevisani","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2019.07.004_bb0255","doi-asserted-by":"crossref","first-page":"28763","DOI":"10.1038\/srep28763","article-title":"Human TRPA1 is a heat sensor displaying intrinsic U-shaped thermosensitivity","volume":"6","author":"Moparthi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2019.07.004_bb0260","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cell.2006.02.023","article-title":"TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents","volume":"124","author":"Bautista","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.tips.2019.07.004_bb0265","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.pain.2011.01.049","article-title":"Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation","volume":"152","author":"Chen","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.tips.2019.07.004_bb0270","doi-asserted-by":"crossref","first-page":"15165","DOI":"10.1523\/JNEUROSCI.2580-10.2010","article-title":"TRPA1 contributes to cold hypersensitivity","volume":"30","author":"del Camino","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.07.004_bb0275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13075-015-0904-y","article-title":"Transient receptor potential ankyrin 1 (TRPA1) receptor is involved in chronic arthritis: in vivo study using TRPA1-deficient mice","volume":"18","author":"Horvath","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.tips.2019.07.004_bb0280","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916677761","article-title":"Selective antagonism of TRPA1 produces limited efficacy in models of inflammatory- and neuropathic-induced mechanical hypersensitivity in rats","volume":"12","author":"Lehto","year":"2016","journal-title":"Mol. Pain"},{"key":"10.1016\/j.tips.2019.07.004_bb0285","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuron.2010.04.030","article-title":"A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome","volume":"66","author":"Kremeyer","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2019.07.004_bb0290","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1523\/JNEUROSCI.5387-13.2014","article-title":"Transient receptor potential channel ankyrin-1 is not a cold sensor for autonomic thermoregulation in rodents","volume":"34","author":"de Oliveira","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.07.004_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/ph11040117","article-title":"TRPA1 antagonists for pain relief","volume":"11","author":"Koivisto","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.tips.2019.07.004_bb0300","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000478986","article-title":"Antinociceptive effects of isosakuranetin in a rat model of peripheral neuropathy","volume":"100","author":"Jia","year":"2017","journal-title":"Pharmacology"},{"key":"10.1016\/j.tips.2019.07.004_bb0305","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/j.pain.0000000000000846","article-title":"Primidone inhibits TRPM3 and attenuates thermal nociception in vivo","volume":"158","author":"Krugel","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.tips.2019.07.004_bb0310","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26147","article-title":"Inhibition of transient receptor potential melastatin 3 ion channels by G-protein betagamma subunits","volume":"6","author":"Badheka","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.tips.2019.07.004_bb0315","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26280","article-title":"Anti-nociceptive action of peripheral mu-opioid receptors by G-beta-gamma protein-mediated inhibition of TRPM3 channels","volume":"6","author":"Dembla","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.tips.2019.07.004_bb0320","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26138","article-title":"G protein betagamma subunits inhibit TRPM3 ion channels in sensory neurons","volume":"6","author":"Quallo","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.tips.2019.07.004_bb0325","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","article-title":"Opioid receptors","volume":"67","author":"Stein","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.tips.2019.07.004_bb0330","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nature26137","article-title":"A TRP channel trio mediates acute noxious heat sensing","volume":"555","author":"Vandewauw","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.07.004_bb0335","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1021\/cn300193h","article-title":"The molecular and cellular basis of cold sensation","volume":"4","author":"McKemy","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tips.2019.07.004_bb0340","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.pain.2013.06.043","article-title":"TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain","volume":"154","author":"Liu","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.tips.2019.07.004_bb0345","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jid.2017.12.025","article-title":"Cooling relief of acute and chronic itch requires TRPM8 channels and neurons","volume":"138","author":"Palkar","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tips.2019.07.004_bb0350","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00210-015-1090-9","article-title":"AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia","volume":"388","author":"Lehto","year":"2015","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.tips.2019.07.004_bb0355","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1021\/acs.jmedchem.8b00545","article-title":"Identification of a potent tryptophan-based TRPM8 antagonist with in vivo analgesic activity","volume":"61","author":"Bertamino","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2019.07.004_bb0360","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.eururo.2015.03.037","article-title":"Essential role of transient receptor potential M8 (TRPM8) in a model of acute cold-induced urinary urgency","volume":"68","author":"Uvin","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tips.2019.07.004_bb0365","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/jpet.114.216010","article-title":"Inhibition of TRPM8 channels reduces pain in the cold pressor test in humans","volume":"351","author":"Winchester","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2019.07.004_bb0370","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ng.856","article-title":"Genome-wide association study reveals three susceptibility loci for common migraine in the general population","volume":"43","author":"Chasman","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2019.07.004_bb0375","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ng.2307","article-title":"Genome-wide association analysis identifies susceptibility loci for migraine without aura","volume":"44","author":"Freilinger","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2019.07.004_bb0380","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/head.12948","article-title":"TRPM8 and migraine","volume":"56","author":"Dussor","year":"2016","journal-title":"Headache"},{"key":"10.1016\/j.tips.2019.07.004_bb0385","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1021\/acs.jmedchem.8b00518","article-title":"Discovery of TRPM8 antagonist ( S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoy l)nicotinic acid (AMG 333), a clinical candidate for the treatment of migraine","volume":"61","author":"Horne","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2019.07.004_bb0390","doi-asserted-by":"crossref","first-page":"17042","DOI":"10.1038\/nrdp.2017.42","article-title":"Urinary incontinence in women","volume":"3","author":"Aoki","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tips.2019.07.004_bb0395","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1359105314522084","article-title":"The psychological impact of overactive bladder: a systematic review","volume":"21","author":"Kinsey","year":"2016","journal-title":"J. Health Psychol."},{"key":"10.1016\/j.tips.2019.07.004_bb0400","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1111\/bph.12502","article-title":"TRP channels in lower urinary tract dysfunction","volume":"171","author":"Franken","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2019.07.004_bb0405","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrurol.2016.13","article-title":"Receptors, channels, and signalling in the urothelial sensory system in the bladder","volume":"13","author":"Merrill","year":"2016","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.tips.2019.07.004_bb0410","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bju.14399","article-title":"Guideline of guidelines: bladder pain syndrome","volume":"122","author":"Malde","year":"2018","journal-title":"BJU Int."},{"key":"10.1016\/j.tips.2019.07.004_bb0415","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrurol.2012.217","article-title":"Intravesical treatments of bladder pain syndrome\/interstitial cystitis","volume":"9","author":"Neuhaus","year":"2012","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.tips.2019.07.004_bb0420","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.12593.1","article-title":"Recent advances in pharmacological management of urinary incontinence","volume":"6","author":"McDonnell","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.tips.2019.07.004_bb0425","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrurol.2015.266","article-title":"Neural control of micturition in humans: a working model","volume":"12","author":"Griffiths","year":"2015","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.tips.2019.07.004_bb0430","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/embor.2012.219","article-title":"The puzzle of TRPV4 channelopathies","volume":"14","author":"Nilius","year":"2013","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tips.2019.07.004_bb0435","doi-asserted-by":"crossref","first-page":"F692","DOI":"10.1152\/ajprenal.00599.2009","article-title":"Functional characterization of transient receptor potential channels in mouse urothelial cells","volume":"298","author":"Everaerts","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.tips.2019.07.004_bb0440","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1172\/JCI31766","article-title":"Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding","volume":"117","author":"Gevaert","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2019.07.004_bb0445","doi-asserted-by":"crossref","first-page":"21257","DOI":"10.1074\/jbc.M109.020206","article-title":"The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures","volume":"284","author":"Mochizuki","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2019.07.004_bb0450","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/nau.23793","article-title":"The time-dependent variation of ATP release in mouse primary-cultured urothelial cells is regulated by the clock gene","volume":"37","author":"Ihara","year":"2018","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.tips.2019.07.004_bb0455","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/nau.23062","article-title":"The Clock mutant mouse is a novel experimental model for nocturia and nocturnal polyuria","volume":"36","author":"Ihara","year":"2017","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.tips.2019.07.004_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168234","article-title":"Clock genes regulate the circadian expression of Piezo1, TRPV4, connexin26, and VNUT in an ex vivo mouse bladder mucosa","volume":"12","author":"Ihara","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2019.07.004_bb0465","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/ncomms1812","article-title":"Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm","volume":"3","author":"Negoro","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2019.07.004_bb0470","doi-asserted-by":"crossref","first-page":"19084","DOI":"10.1073\/pnas.1005333107","article-title":"Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis","volume":"107","author":"Everaerts","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2019.07.004_bb0475","doi-asserted-by":"crossref","first-page":"R471","DOI":"10.1152\/ajpregu.00008.2014","article-title":"Intravesical TRPV4 blockade reduces repeated variate stress-induced bladder dysfunction by increasing bladder capacity and decreasing voiding frequency in male rats","volume":"307","author":"Merrill","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.tips.2019.07.004_bb0480","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40256-018-00320-6","article-title":"Clinical pharmacokinetics, safety, and tolerability of a novel, first-in-class TRPV4 ion channel inhibitor, GSK2798745, in healthy and heart failure subjects","volume":"19","author":"Goyal","year":"2019","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.tips.2019.07.004_bb0485","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.eururo.2018.05.020","article-title":"Intravesical activation of the cation channel TRPV4 improves bladder function in a rat model for detrusor underactivity","volume":"74","author":"Deruyver","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tips.2019.07.004_bb0490","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/nau.23790","article-title":"Effect of TRPV4 activation in a rat model of detrusor underactivity induced by bilateral pelvic nerve crush injury","volume":"37","author":"Takaoka","year":"2018","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.tips.2019.07.004_bb0495","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1124\/jpet.107.134551","article-title":"Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2","volume":"326","author":"Willette","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2019.07.004_bb0500","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jconrel.2014.04.049","article-title":"Single compartment drug delivery","volume":"190","author":"Cima","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tips.2019.07.004_bb0505","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2017.08.120","article-title":"Advances in intravesical drug delivery systems to treat bladder cancer","volume":"532","author":"Kolawole","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tips.2019.07.004_bb0510","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"American Diabetes, A.","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tips.2019.07.004_bb0515","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/dom.12935","article-title":"Improving glycaemic control in type 2 diabetes: stimulate insulin secretion or provide beta-cell rest?","volume":"19","author":"van Raalte","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tips.2019.07.004_bb0520","series-title":"Neurobiology of TRP Channels","first-page":"229","article-title":"The role of TRP channels in the pancreatic beta-cell","author":"Philippaert","year":"2017"},{"key":"10.1016\/j.tips.2019.07.004_bb0525","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1073\/pnas.0913107107","article-title":"Loss of high-frequency glucose-induced Ca2+ oscillations in pancreatic islets correlates with impaired glucose tolerance in Trpm5-\/- mice","volume":"107","author":"Colsoul","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2019.07.004_bb0530","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1038\/ncomms14733","article-title":"Steviol glycosides enhance pancreatic beta-cell function and taste sensation by potentiation of TRPM5 channel activity","volume":"8","author":"Philippaert","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2019.07.004_bb0535","doi-asserted-by":"crossref","DOI":"10.1111\/apha.12949","article-title":"TRPM5 in the battle against diabetes and obesity","volume":"222","author":"Vennekens","year":"2018","journal-title":"Acta Physiol. (Oxford)"},{"key":"10.1016\/j.tips.2019.07.004_bb0540","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1172\/JCI81975","article-title":"GLP-1 stimulates insulin secretion by PKC-dependent TRPM4 and TRPM5 activation","volume":"125","author":"Shigeto","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2019.07.004_bb0545","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00424-013-1389-7","article-title":"Insulin downregulates the expression of the Ca2+-activated nonselective cation channel TRPM5 in pancreatic islets from leptin-deficient mouse models","volume":"466","author":"Colsoul","year":"2013","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.tips.2019.07.004_bb0550","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.metabol.2011.02.002","article-title":"Genetic variation within the TRPM5 locus associates with prediabetic phenotypes in subjects at increased risk for type 2 diabetes","volume":"60","author":"Ketterer","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.tips.2019.07.004_bb0555","first-page":"1388","article-title":"Role of the transient receptor potential (TRP) channel gene expressions and TRP melastatin (TRPM) channel gene polymorphisms in obesity-related metabolic syndrome","volume":"19","author":"Tabur","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.tips.2019.07.004_bb0560","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12750","article-title":"RNA-sequencing of WFS1-deficient pancreatic islets","volume":"4","author":"Ivask","year":"2016","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.tips.2019.07.004_bb0565","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0026-0495(00)91325-8","article-title":"Stevioside acts directly on pancreatic beta cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity","volume":"49","author":"Jeppesen","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.tips.2019.07.004_bb0570","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.metabol.2004.04.014","article-title":"Rebaudioside A potently stimulates insulin secretion from isolated mouse islets: studies on the dose-, glucose-, and calcium-dependency","volume":"53","author":"Abudula","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.tips.2019.07.004_bb0575","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.metabol.2005.03.026","article-title":"Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats","volume":"54","author":"Dyrskog","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.tips.2019.07.004_bb0580","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1900\/RDS.2006.3.189","article-title":"Can stevioside in combination with a soy-based dietary supplement be a new useful treatment of type 2 diabetes? An in vivo study in the diabetic goto-kakizaki rat","volume":"3","author":"Jeppesen","year":"2006","journal-title":"Rev. Diabet. Stud."},{"key":"10.1016\/j.tips.2019.07.004_bb0585","first-page":"164","article-title":"Metabolism of stevioside by healthy subjects","volume":"232","author":"Geuns","year":"2007","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.tips.2019.07.004_bb0590","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.metabol.2003.07.013","article-title":"Antihyperglycemic effects of stevioside in type 2 diabetic subjects","volume":"53","author":"Gregersen","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.tips.2019.07.004_bb0595","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nrd1225","article-title":"COX-2 and beyond: approaches to prostaglandin inhibition in human disease","volume":"2","author":"FitzGerald","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2019.07.004_bb0600","doi-asserted-by":"crossref","first-page":"j1909","DOI":"10.1136\/bmj.j1909","article-title":"Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data","volume":"357","author":"Bally","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.tips.2019.07.004_bb0605","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.gastro.2017.10.049","article-title":"Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs","volume":"154","author":"Bjarnason","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2019.07.004_bb0610","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phrs.2016.02.020","article-title":"Acetaminophen from liver to brain: new insights into drug pharmacological action and toxicity","volume":"109","author":"Ghanem","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tips.2019.07.004_bb0615","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ncomms1559","article-title":"TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Delta(9)-tetrahydrocannabiorcol","volume":"2","author":"Andersson","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2019.07.004_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012748","article-title":"TRPV1 in brain is involved in acetaminophen-induced antinociception","volume":"5","author":"Mallet","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2019.07.004_bb0625","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/ALN.0000000000001700","article-title":"Acetaminophen metabolite N-acylphenolamine induces analgesia via transient receptor potential vanilloid 1 receptors expressed on the primary afferent terminals of C-fibers in the spinal dorsal horn","volume":"127","author":"Ohashi","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.tips.2019.07.004_bb0630","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2016.06.057","article-title":"Antidepressants and gabapentinoids in neuropathic pain: mechanistic insights","volume":"338","author":"Kremer","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2019.07.004_bb0635","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.eururo.2013.10.033","article-title":"An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders","volume":"65","author":"Mangera","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tips.2019.07.004_bb0640","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.4111\/icu.2017.58.S2.S99","article-title":"New therapeutic directions to treat underactive bladder","volume":"58","author":"Chai","year":"2017","journal-title":"Investig. Clin. Urol."},{"key":"10.1016\/j.tips.2019.07.004_bb0645","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/jama.2015.9536","article-title":"Diabetes: advances in diagnosis and treatment","volume":"314","author":"Nathan","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.tips.2019.07.004_bb0650","doi-asserted-by":"crossref","first-page":"i3625","DOI":"10.1136\/bmj.i3625","article-title":"Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study","volume":"354","author":"van Dalem","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.tips.2019.07.004_bb0655","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s13300-018-0488-z","article-title":"Safety and efficacy of DPP4 inhibitor and basal insulin in type 2 diabetes: an updated review and challenging clinical scenarios","volume":"9","author":"Gomez-Peralta","year":"2018","journal-title":"Diabetes Ther."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614719301415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614719301415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:07:57Z","timestamp":1759050477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614719301415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":131,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0165614719301415"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2019.07.004","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting TRP Channels \u2013 Valuable Alternatives to Combat Pain, Lower Urinary Tract Disorders, and Type 2 Diabetes?","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}